China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015)
China Pharma Holdings' (CPHI) quarterly Construction in Progress came in at $19747.0 in Q3 2015, down 99.84% on a YoY basis from $12.5 million in Q3 2014, and up 234.92% quarter-over-quarter from $5896.0 in Q2 2015.
Analysis
China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015) Analysis & Trends
China Pharma Holdings (CPHI) has reported Construction in Progress for 5 consecutive years, with $19747.0 the latest figure, recorded in Q3 2015.
- For the quarter ending Q3 2015, Construction in Progress fell 99.84% year-over-year to $19747.0; the trailing twelve-month figure through Sep 2015 stood at $19747.0 (down 99.84% YoY), and the FY2014 full-year result was $5848.0, down 99.98% from the prior year.
- Construction in Progress grew to $19747.0 in Q3 2015 per CPHI's latest filing, from $5896.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $29.7 million in Q2 2014 and bottomed at $5848.0 in Q4 2014.
- Historically, Construction in Progress has averaged $8.8 million across 5 years, with a median of $3.7 million in 2012.
- The sharpest annual moves came in 2013 and 2015: Construction in Progress soared 4227.86% in 2013, then sank 99.98% in 2015.
- Over 5 years, Construction in Progress stood at $351571.0 in 2011, then soared by 949.17% to $3.7 million in 2012, then surged by 591.26% to $25.5 million in 2013, then slumped by 99.98% to $5848.0 in 2014, then jumped by 237.67% to $19747.0 in 2015.
- According to Business Quant data, Construction in Progress over the past three periods registered $19747.0, $5896.0, and $5876.0 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 19,747.00 |
| Jun 30, 2015 | 5,896.00 |
| Mar 31, 2015 | 5,876.00 |
| Dec 31, 2014 | 5,848.00 |
| Sep 30, 2014 | 12.54 Mn |
| Jun 30, 2014 | 29.72 Mn |
| Mar 31, 2014 | 29.01 Mn |
| Dec 31, 2013 | 25.50 Mn |
| Sep 30, 2013 | 15.67 Mn |
| Jun 30, 2013 | 10.34 Mn |
| Mar 31, 2013 | 4.13 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 361,999.00 |
| Jun 30, 2012 | 354,034.00 |
| Dec 31, 2011 | 351,571.00 |